Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis.

ABSTRACT:

Background

The prognostic value of preoperative fluorine-18-fluorodeoxyglucose positron-emission tomography (¹⁸F-FDG PET) scan for determining overall survival (OS) in breast cancer (BC) patients is controversial.

Aim

To evaluate the OS predictive value of preoperative PET positivity after 15 years.

Methods

We performed a retrospective search of the Universitair Ziekenhuis Brussel patient database for nonmetastatic patients who underwent preoperative PET between 2002-2008. PET positivity was determined by anatomical region of interest (AROI) findings for breast and axillary, sternal, and distant sites. The prognostic role of PET was examined as a qualitative binary factor (positive vs negative status) and as a continuous variable [maximum standard up

SUBMITTER: Perrin J 

PROVIDER: S-EPMC9052070 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature